Epiretinal Membrane Forecast in 12 Major Markets 2017-2027

February 2017 | 56 pages | ID: E4689C65E5EEN
Black Swan Analysis limited

Abstracts

Overactive Bladder (OAB) is a (relatively) common, disabling condition associated with significant negative impact on quality of life, sleep and mental health. It is characterised as a sudden, strong uncontrollable urge to urinate.

This report provides the current prevalent population for Overactive Bladder across 12 Major Markets (USA, Canada, France, Germany, Russia, Italy, Spain, UK, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Overactive Bladder have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Patients with OAB often also have other bladder-related symptoms such as:

• Nocturia
• Urgency issues
• Frequency issues
• Issues with voiding
• Urge urinary incontinence (UUI)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Overactive Bladder market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Overactive Bladder and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Overactive Bladder’s prevalent population.
• Identify sub-populations within Overactive Bladder which require treatment.
• Gain an understanding of the specific markets that have the largest number of Overactive Bladder patients.

Contents

Introduction
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Methodology for quantification of patient numbers
Top-line Prevalence for Epiretinal Membrane
Features of Epiretinal Membrane Patients
o Cause of Epiretinal Membranes
o Comorbidities in patients with Epiretinal Membrane
o Comorbidities in patients with Idiopathic ERM
o Comorbidities in patients with ERM due to secondary causes
Abbreviations used in the report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix

List Of Figures

LIST OF FIGURES

OCT image of the retina showing formation of an epiretinal membrane
The Age-Related Eye Disease Study maculopathy grading grid, affixed to the photograph of a left eye without age-related macular degeneration

List Of Tables

LIST OF TABLES

Prevalence of Epiretinal Membrane, total (000s)
Prevalence of Epiretinal Membrane, males (000s)
Prevalence of Epiretinal Membrane, females (000s)
Eye affected by ERM, total (000s)
Type of ERM, total (000s)
Cause of Epiretinal Membrane, total (000s)
Cause of CMR, total (000s)
Cause of PMF, total (000s)
Type of Adhesion in Idiopathic ERM, total (000s)
Type of Adhesion in Secondary ERM patients, total (000s)
ERM patients with Posterior Straphyloma, total (000s)
ERM patients with PVD, total (000s)
ERM patients with Metamophopsia, total (000s)
ERM patients with Diabetes, total (000s)
ERM patients with Hypertension, total (000s)
ERM patients with Macular Hole, total (000s)
ERM patients with PED, total (000s)
ERM patients with CME, total (000s)
ERM patients with High Myopia, total (000s)
Idiopathic ERM patients with VMT, total (000s)
Idiopathic ERM patients with Macular Pseudohole, total (000s)
Secondary ERM patients with VMT, total (000s)
Secondary ERM patients with Diabetes, total (000s)
Secondary ERM patients with BRVO, total (000s)
Secondary ERM patients with CRVO, total (000s)
Secondary ERM patients with Retinal Detachment, total (000s)
Secondary ERM patients with AMD, total (000s)
Secondary ERM patients with PDR, total (000s
Abbreviations and Acronyms used in the report
USA Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
USA Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Canada Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Canada Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
France Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
France Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Germany Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Germany Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Italy Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Italy Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Spain Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Spain Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
UK Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
UK Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Brazil Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Brazil Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Japan Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Japan Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
India Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
India Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Australia Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
Australia Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
China Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
China Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)